Clinical Trial Update: A Dose-escalation Study in Subjects With Advanced Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation study in patients with advanced malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Incyte Corporation | Conditions: Solid Tumor, Advanced Cancer | Phase 1 | Status: COMPLETED